Pyxis Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PFIZER INC | 02/14/2025 | 7.03 M | $10.97 M | 100.00% | 11.58% |
LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 3.63 M | $5.66 M | 0.00% | 5.97% |
BLACKROCK, INC. | 02/07/2025 | 3.34 M | $5.22 M | 12.82% | 5.51% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.98 M | $4.65 M | 56.32% | 4.91% |
VANGUARD GROUP INC | 02/11/2025 | 2.44 M | $3.81 M | 0.34% | 4.02% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.08 M | $1.69 M | -0.21% | 1.78% |
PALO ALTO INVESTORS LP | 02/14/2025 | 1.04 M | $1.62 M | 510.25% | 1.71% |
STATE STREET CORP | 02/14/2025 | 944.17 K | $1.47 M | -0.74% | 1.56% |
ABRDN PLC | 01/24/2025 | 913.05 K | $1.42 M | 0.00% | 1.50% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 832.20 K | $1.30 M | 3,396.64% | 1.37% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 613.25 K | $956.68 K | -35.95% | 1.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 601.94 K | $939.03 K | 57.23% | 0.99% |
UBS GROUP AG | 02/14/2025 | 446.70 K | $696.85 K | 1,489.56% | 0.74% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 415.00 K | $647.40 K | 0.08% | 0.68% |
HHLR ADVISORS, LTD. | 02/14/2025 | 382.61 K | $596.87 K | 0.00% | 0.63% |
NORTHERN TRUST CORP | 02/14/2025 | 378.59 K | $590.59 K | -3.92% | 0.62% |
RIDGEBACK CAPITAL INVESTMENTS L.P. | 02/14/2025 | 359.23 K | $560.40 K | 100.00% | 0.59% |
DECHENG CAPITAL LLC | 02/14/2025 | 326.81 K | $509.82 K | 0.00% | 0.54% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 299.94 K | $467.90 K | 88.12% | 0.49% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 293.35 K | $457.63 K | 82.96% | 0.48% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 272.77 K | $425.52 K | 0.00% | 0.45% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 270.00 K | $421.19 K | 1.77% | 0.44% |
MORGAN STANLEY | 02/14/2025 | 242.73 K | $378.66 K | 58.39% | 0.40% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 188.46 K | $294.00 K | -62.93% | 0.31% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 184.70 K | $288.14 K | 32.75% | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 181.04 K | $282.43 K | -36.17% | 0.30% |
MARSHALL WACE, LLP | 02/13/2025 | 157.95 K | $246.41 K | 35.75% | 0.26% |
UBS OCONNOR LLC | 02/14/2025 | 146.40 K | $228.38 K | 100.00% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 129.76 K | $202.43 K | 0.00% | 0.21% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 127.30 K | $198.59 K | -14.57% | 0.21% |
ARISTIDES CAPITAL LLC | 02/13/2025 | 124.00 K | $193.44 K | 100.00% | 0.20% |
SCHULHOFF & CO INC | 02/05/2025 | 122.00 K | $190.32 K | 0.00% | 0.20% |
MAIA WEALTH LLC | 02/05/2025 | 118.90 K | $951 | 100.00% | 0.20% |
NEWEDGE WEALTH, LLC | 02/05/2025 | 116.01 K | $180.97 K | 0.00% | 0.19% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 111.05 K | $173.24 K | 35.52% | 0.18% |
PIER 88 INVESTMENT PARTNERS LLC | 02/12/2025 | 98.59 K | $153.80 K | -18.93% | 0.16% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 85.60 K | $133.54 K | 100.00% | 0.14% |
FMR LLC | 02/13/2025 | 84.89 K | $132.43 K | 2,037.16% | 0.14% |
LMR PARTNERS LLP | 02/14/2025 | 77.30 K | $120.59 K | -3.38% | 0.13% |
BARCLAYS PLC | 02/13/2025 | 77.01 K | $121.00 K | 20.17% | 0.13% |
YU FAN | 02/14/2025 | 69.30 K | $108.11 K | 0.00% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 67.98 K | $106.04 K | -20.79% | 0.11% |
RHUMBLINE ADVISERS | 01/30/2025 | 67.85 K | $105.84 K | 5.31% | 0.11% |
JANE STREET GROUP, LLC | 02/14/2025 | 67.69 K | $105.59 K | 36.58% | 0.11% |
CABLE CAR CAPITAL LLC | 02/14/2025 | 61.61 K | $96.11 K | 0.00% | 0.10% |
SEI INVESTMENTS CO | 02/11/2025 | 61.14 K | $95.38 K | 100.00% | 0.10% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 53.75 K | $83.84 K | 20.28% | 0.09% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 50.08 K | $78.13 K | 100.00% | 0.08% |
UNIVERSITY OF CHICAGO | 02/05/2025 | 48.73 K | $76.02 K | 0.00% | 0.08% |
CITADEL ADVISORS LLC | 02/14/2025 | 42.60 K | $66.46 K | 68.38% | 0.07% |
Pyxis Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 100 institutional investors and hedge funds held shares of Pyxis Oncology, Inc.. The most heavily invested institutionals were:
PFIZER INC: 7.03 M
Laurion Capital Management LP: 3.63 M
MILLENNIUM MANAGEMENT LLC: 2.98 M
VANGUARD GROUP INC: 2.44 M
GEODE CAPITAL MANAGEMENT, LLC: 1.08 M
Palo Alto Investors LP: 1.04 M
51.94% of Pyxis Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31.55 M shares in the last 24 months. This purchase volume represents approximately $33.76 M in transactions.